**Job Description**
Cedars-Sinai is committed to pushing the frontiers of medicine and discovering new technologies and innovations that will change how we diagnose and treat disease. As an international leader in biomedical research, we translate discoveries into successful treatments with global impact. With your help, we can change the future of healthcare!
**Are you ready to be a part of breakthrough research?**
The Gibb Laboratory investigates inflammatory mechanisms in patients with sickle cell disease (SCD) and lupus, focusing on mechanisms regulating immune responses to red blood cell (RBC) antigens (i.e., KEL antigens) following RBC transfusion. The goal of these studies is to understand why patients with SCD and autoimmunity have the highest incidence of these detrimental anti-RBC antibody responses, which cause potentially fatal hemolytic transfusion reactions and severely limit access to compatible blood for these populations. Specifically, the lab has uncovered a ...